Ternatin
Latest Information Update: 16 Feb 1998
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antiplatelets; Hepatoprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 16 Feb 1998 No-Development-Reported for Thrombosis in Brazil (Unknown route)
- 06 Sep 1995 Preclinical development for Thrombosis in Brazil (Unknown route)